Elise Reuter

Denver

Reporter @MedTechDive covering medical devices and digital therapeutics. Tips: ereuter at industrydive dot com or 619 736 9409 for Signal. She/her.

Articles

New Insulet CEO Ashley McEvoy sets priorities

5 days ago | medtechdive.com | Elise Reuter

By the numbersQ1 revenue: $569 million29% increase year over yearNet income: $35.4 million31% decrease year over yearNew Insulet CEO Ashley McEvoy set out her priorities for the diabetes technology company on Thursday. “Insulet is already a standout success story,” McEvoy told investors during her first call after taking on the role, adding that the firm is one of the fastest-growing businesses in medtech.
New Insulet CEO Ashley McEvoy sets priorities

5 days ago | finance.yahoo.com | Elise Reuter

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers Q1 revenue: $569 million 29% increase year over year Net income: $35.4 million 31% decrease year over year New Insulet CEO Ashley McEvoy set out her priorities for the diabetes technology company on Thursday.
ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards

5 days ago | medtechdive.com | Elise Reuter

A growing number of diabetes technology companies are advocating for greater access to medical devices for people with Type 2 diabetes. In the last year, the Food and Drug Administration has granted the first expanded indications for automated insulin delivery systems in people with Type 2 diabetes. The systems combine pumps and glucose monitors to automatically adjust insulin delivery based on blood glucose levels.
Zimmer Biomet expects $60M to $80M tariff impact this year

1 week ago | finance.yahoo.com | Elise Reuter

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers Q1 revenue: $1.91 billion 1.1% increase year over year Net income: $182.6 million 5.6% increase year over year Zimmer Biomet expects a $60 million to $80 million impact to its operating profit from tariffs this year, CFO Suketu Upadhyay told investors Monday.
RFK’s FDA layoffs could slow safety communications, experts warn

1 week ago | medtechdive.com | Elise Reuter

Mass staff cuts at the Food and Drug Administration could affect public notices about medical device recalls and other product safety issues, experts told MedTech Dive. Many communications staff in the FDA’s Center for Devices and Radiological Health were cut in early April after the Department of Health and Human Services unveiled a plan to lay off about 10,000 employees.
FDA layoffs could slow safety communications, experts warn

1 week ago | biopharmadive.com | Elise Reuter

Mass staff cuts at the Food and Drug Administration could affect public notices about medical device recalls and other product safety issues, experts told MedTech Dive. Many communications staff in the FDA’s Center for Devices and Radiological Health were cut in early April after the Department of Health and Human Services unveiled a plan to lay off about 10,000 employees.
Zimmer Biomet expects $60M to $80M tariff impact this year

1 week ago | medtechdive.com | Elise Reuter

By the numbersQ1 revenue: $1.91 billion1.1% increase year over yearNet income: $182.6 million5.6% increase year over yearZimmer Biomet expects a $60 million to $80 million impact to its operating profit from tariffs this year, CFO Suketu Upadhyay told investors Monday. That estimate accounts for “current administration proposals,” Upadhyay said, including announced European reciprocal tariffs going into effect after a 90-day stay. Most of the impact is expected in the second half of the year.
Stryker expects $200M tariff hit, lowers earnings forecast

1 week ago | finance.yahoo.com | Elise Reuter

Unlock stock picks and a broker-level newsfeed that powers Wall Street. Elise Reuter Fri, May 2, 2025, 4:18 AM 3 min read In This Article: This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter.
Stryker expects $200M tariff hit, lowers earnings forecast

1 week ago | medtechdive.com | Elise Reuter

By the numbersQ1 sales: $5.9 billion11.9% increase year over yearNet earnings: $654 million17% decrease year over yearStryker expects a $200 million hit to its 2025 earnings from tariffs, the latest medical device company to call out impacts of hundreds of millions of dollars. CFO Preston Wells told investors Thursday that the estimate is based on tariffs that are currently in effect. It does not include the impact of tariffs that were paused for 90 days.
Senators call for investigation into BCI privacy

2 weeks ago | medtechdive.com | Elise Reuter

Three Democratic senators sent a letter to the Federal Trade Commission on Monday calling for safeguards on neural data collected by brain computer interface companies. The letter cited a 2024 report that found consumer neurotechnology companies largely don’t limit access to users’ neural data. The lawmakers called for baseline disclosure and transparency standards for all BCI devices, whether for wellness or medical purposes, and whether or not they are invasive.